Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
MannKind Corp
MNKD
$1.17B
| $2.29M | ﹤0.01% |
558,847
-147,041
| -21% | -$709K |
|
2052
Mueller Industries
MLI
$14.7B
| $2.28M | ﹤0.01% |
124,216
+12,496
| +11% | +$218K |
|
2053
PUT
ConocoPhillips
COP
$145B
| $2.28M | ﹤0.01% |
23,000
-197,000
| -90% | -$21.6M |
|
2054
Globant
GLOB
$1.6B
| $2.28M | ﹤0.01% |
13,898
+11,732
| +542% | +$1.92M |
|
2055
First American
FAF
$7.7B
| $2.28M | ﹤0.01% |
40,903
+13,744
| +51% | +$789K |
|
2056
Gulfport Energy Corp
GPOR
$2.94B
| $2.28M | ﹤0.01% |
28,446
+23,844
| +518% | +$1.73M |
|
|
LCW
2057
DELISTED
Learn CW Investment Corporation Class A Ordinary Shares
LCW
| $2.27M | ﹤0.01% |
220,973
| – | – |
|
|
CTIC
2058
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $2.26M | ﹤0.01% |
536,999
-221,362
| -29% | -$1.15M |
|
2059
NOV
NOV
$6.94B
| $2.25M | ﹤0.01% |
121,798
+52,671
| +76% | +$1.14M |
|
2060
Houlihan Lokey
HLI
$8.77B
| $2.25M | ﹤0.01% |
25,720
+2,660
| +12% | +$250K |
|
2061
CALL
CarMax
KMX
$8.29B
| $2.25M | ﹤0.01% |
+35,000
| New | +$2.34M |
|
|
2062
PUT
CarMax
KMX
$8.29B
| $2.25M | ﹤0.01% |
+35,000
| New | +$2.34M |
|
|
DVAX
2063
DELISTED
Dynavax Technologies
DVAX
| $2.24M | ﹤0.01% |
228,818
-150,343
| -40% | -$1.6M |
|
2064
Telus
TU
$15B
| $2.24M | ﹤0.01% |
112,998
-83,386
| -42% | -$1.7M |
|
2065
Yelp
YELP
$1.47B
| $2.24M | ﹤0.01% |
73,073
-5,036
| -6% | -$151K |
|
|
NIMC
2066
DELISTED
NiSource Inc. Series A Corporate Units
NIMC
| $2.24M | ﹤0.01% |
+21,446
| New | +$2.22M |
|
2067
Evolent Health
EVH
$353M
| $2.23M | ﹤0.01% |
68,869
-25,273
| -27% | -$799K |
|
2068
CALL
Edwards Lifesciences
EW
$51.1B
| $2.23M | ﹤0.01% |
+27,000
| New | +$2.12M |
|
2069
Cameco
CCJ
$39.1B
| $2.23M | ﹤0.01% |
85,207
-54,505
| -39% | -$1.44M |
|
2070
PUT
Credicorp
BAP
$31.4B
| $2.22M | ﹤0.01% |
+16,800
| New | +$2.25M |
|
2071
Elbit Systems
ESLT
$38.9B
| $2.22M | ﹤0.01% |
13,063
+5,969
| +84% | +$1.02M |
|
2072
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $2.22M | ﹤0.01% |
71,200
-825,912
| -92% | -$26.5M |
|
2073
Brookfield
BN
$107B
| $2.22M | ﹤0.01% |
102,237
+66,552
| +186% | +$1.5M |
|
2074
CALL
Conagra Brands
CAG
$7.14B
| $2.22M | ﹤0.01% |
59,100
-1,100
| -2% | -$40.8K |
|
2075
Starwood Property Trust
STWD
$5.92B
| $2.22M | ﹤0.01% |
125,324
+49,733
| +66% | +$960K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.